Literature DB >> 22977561

Sessile serrated adenoma shares similar genetic and epigenetic features with microsatellite unstable colon cancer in a location-dependent manner.

Takafumi Maeda1, Koichi Suzuki, Kazutomo Togashi, Mitsuhiro Nokubi, Masaaki Saito, Shingo Tsujinaka, Hidenori Kamiyama, Fumio Konishi.   

Abstract

Genetic and epigenetic features of sessile serrated adenoma (SSA), a precursor lesion to colon cancer with microsatellite instability (MSI), were investigated. The aim of this study was to clarify whether there are location-dependent genetic and epigenetic features in SSA. Twenty-two patients with proximal SSAs and 8 with distal SSAs were recruited. Twenty-two patients with tubular adenoma (TA) and 66 with proximal colon cancer were studied for comparison. Genetic and epigenetic features were evaluated as BRAF and KRAS mutations, MSI, hMLH1 methylation and CpG island methylator phenotype (CIMP). BRAF mutation (p=0.007) and CIMP (p=0.012) were more frequently found in proximal than in distal SSAs. Furthermore, the KRAS mutation was found only in distal SSAs. In TAs, no location-related molecular features were observed. All SSAs, TAs and 42 colon cancer lesions were microsatellite stable (MSS). Twenty-four colon cancer lesions exhibited MSI and had more frequent BRAF mutations (p<0.001), hMLH1 methylation (p<0.001) and CIMP (p<0.001). BRAF mutation occurred in only 9.5% of MSS cancers (p=0.01). In MSI cancers with the BRAF mutation, a higher correlation with CIMP (p=0.032) was observed. We demonstrated the distinct genetic and epigenetic features between proximal and distal SSAs. Similar genetic and epigenetic features were shared between proximal SSAs and proximal MSI cancers harboring the BRAF mutation. By contrast, our results allow the possibility of carcinogenesis in SSAs leading to MSS cancer with the BRAF mutation.

Entities:  

Year:  2011        PMID: 22977561      PMCID: PMC3440750          DOI: 10.3892/etm.2011.249

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  32 in total

1.  The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients.

Authors:  A Fariña-Sarasqueta; G van Lijnschoten; E Moerland; G-J Creemers; V E P P Lemmens; H J T Rutten; A J C van den Brule
Journal:  Ann Oncol       Date:  2010-05-25       Impact factor: 32.976

2.  CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer.

Authors:  Shuji Ogino; Katsuhiko Nosho; Gregory J Kirkner; Takako Kawasaki; Jeffrey A Meyerhardt; Massimo Loda; Edward L Giovannucci; Charles S Fuchs
Journal:  Gut       Date:  2008-10-02       Impact factor: 23.059

3.  COBRA: a sensitive and quantitative DNA methylation assay.

Authors:  Z Xiong; P W Laird
Journal:  Nucleic Acids Res       Date:  1997-06-15       Impact factor: 16.971

4.  CpG island methylator phenotype in colorectal cancer.

Authors:  M Toyota; N Ahuja; M Ohe-Toyota; J G Herman; S B Baylin; J P Issa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

Review 5.  Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia.

Authors:  T A Longacre; C M Fenoglio-Preiser
Journal:  Am J Surg Pathol       Date:  1990-06       Impact factor: 6.394

6.  Serrated polyps of the large intestine: a molecular study comparing sessile serrated adenomas and hyperplastic polyps.

Authors:  Dominique Sandmeier; Jean Benhattar; Patricia Martin; Hanifa Bouzourene
Journal:  Histopathology       Date:  2009-08       Impact factor: 5.087

7.  Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps.

Authors:  Yong Ho Kim; Sanjay Kakar; Lisa Cun; Guoren Deng; Young S Kim
Journal:  Int J Cancer       Date:  2008-12-01       Impact factor: 7.396

8.  Morphologic reappraisal of serrated colorectal polyps.

Authors:  Emina Torlakovic; Eva Skovlund; Dale C Snover; Goran Torlakovic; Jahn M Nesland
Journal:  Am J Surg Pathol       Date:  2003-01       Impact factor: 6.394

9.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

10.  Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer.

Authors:  J R Jass; K Baker; I Zlobec; T Higuchi; M Barker; D Buchanan; J Young
Journal:  Histopathology       Date:  2006-08       Impact factor: 5.087

View more
  16 in total

1.  Immune environment in serrated lesions of the colon: intraepithelial lymphocyte density, PD-1, and PD-L1 expression correlate with serrated neoplasia pathway progression.

Authors:  Gabriel Acosta-Gonzalez; Madhu Ouseph; Kara Lombardo; Shaolei Lu; Jonathan Glickman; Murray B Resnick
Journal:  Hum Pathol       Date:  2018-08-31       Impact factor: 3.466

Review 2.  Accumulation of aberrant DNA methylation during colorectal cancer development.

Authors:  Eiji Sakai; Atsushi Nakajima; Atsushi Kaneda
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

3.  Loss of Hes1 Differentiates Sessile Serrated Adenoma/Polyp From Hyperplastic Polyp.

Authors:  Min Cui; Amad Awadallah; Wendy Liu; Lan Zhou; Wei Xin
Journal:  Am J Surg Pathol       Date:  2016-01       Impact factor: 6.394

Review 4.  Establishing a biological profile for interval colorectal cancers.

Authors:  Amy L Cisyk; Harminder Singh; Kirk J McManus
Journal:  Dig Dis Sci       Date:  2014-05-20       Impact factor: 3.199

5.  Genetic and epigenetic aberrations occurring in colorectal tumors associated with serrated pathway.

Authors:  Eiji Sakai; Masaki Fukuyo; Ken Ohata; Keisuke Matsusaka; Noriteru Doi; Yasunobu Mano; Kiyoko Takane; Hiroyuki Abe; Koichi Yagi; Nobuyuki Matsuhashi; Junichi Fukushima; Masashi Fukayama; Kiwamu Akagi; Hiroyuki Aburatani; Atsushi Nakajima; Atsushi Kaneda
Journal:  Int J Cancer       Date:  2015-11-12       Impact factor: 7.396

6.  Cell-surface markers for colon adenoma and adenocarcinoma.

Authors:  Kamini Sewda; Domenico Coppola; Steven Enkemann; Binglin Yue; Jongphil Kim; Alexis S Lopez; Jonathan W Wojtkowiak; Valerie E Stark; Brian Morse; David Shibata; Shivakumar Vignesh; David L Morse
Journal:  Oncotarget       Date:  2016-04-05

7.  B-RAF mutation and accumulated gene methylation in aberrant crypt foci (ACF), sessile serrated adenoma/polyp (SSA/P) and cancer in SSA/P.

Authors:  A Inoue; K Okamoto; Y Fujino; T Nakagawa; N Muguruma; K Sannomiya; Y Mitsui; T Takaoka; S Kitamura; H Miyamoto; T Okahisa; T Fujimori; I Imoto; T Takayama
Journal:  Br J Cancer       Date:  2014-10-14       Impact factor: 7.640

8.  DNA methylation alterations of AXIN2 in serrated adenomas and colon carcinomas with microsatellite instability.

Authors:  Yuta Muto; Takafumi Maeda; Koichi Suzuki; Takaharu Kato; Fumiaki Watanabe; Hidenori Kamiyama; Masaaki Saito; Kei Koizumi; Yuichiro Miyaki; Fumio Konishi; Sergio Alonso; Manuel Perucho; Toshiki Rikiyama
Journal:  BMC Cancer       Date:  2014-06-25       Impact factor: 4.430

9.  The CIMP Phenotype in BRAF Mutant Serrated Polyps from a Prospective Colonoscopy Patient Cohort.

Authors:  Winnie C Fernando; Mariska S Miranda; Daniel L Worthley; Kazutomo Togashi; Dianne J Watters; Barbara A Leggett; Kevin J Spring
Journal:  Gastroenterol Res Pract       Date:  2014-04-10       Impact factor: 2.260

10.  TP53 mutation at early stage of colorectal cancer progression from two types of laterally spreading tumors.

Authors:  Eiji Sakai; Masaki Fukuyo; Keisuke Matsusaka; Ken Ohata; Noriteru Doi; Kiyoko Takane; Nobuyuki Matsuhashi; Junichi Fukushima; Atsushi Nakajima; Atsushi Kaneda
Journal:  Cancer Sci       Date:  2016-04-27       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.